Cadila Pharmaceuticals has achieved distinction at the CII Industrial Innovation Awards 2023. Acknowledged as one of the "Top 50 Innovative Companies of India," Cadila Pharmaceuticals' commitment to innovation has earned this recognition.

Raj Prakash Vyas, President of Corporate Affairs at Cadila Pharmaceuticals, received the award on behalf of the company in a ceremony attended by key opinion leaders and notable figures from India's corporate realm. The event was graced by esteemed personalities such as Dr. Parvinder Maini, Scientific Secretary at the Office of the Principal Scientific Adviser to the Government of India, Vipin Sondhi, Chairman of CII Industrial Innovation Awards 2023, and Alok Nanda, Co-chairman of CII Industrial Innovation Awards 2023.

Among the groundbreaking innovations from Cadila, showcased were Rabeloc IV, Sepsivac, Polycap, Resorine, Cadiflu, MycidacC, ThRabis, and others. These innovations, Vyas emphasized, represent the company's commitment to advancing healthcare solutions that have the potential to reshape the landscape of public health in India.

"At Cadila Pharmaceuticals, our focus on innovation is not just about creating medicines; it's about catalyzing positive change. Our innovations are designed to address critical public health problems, contributing to a healthier and more resilient society," affirmed Vyas.